Attendees at this year’s Complex Cardiovascular Catheter Therapeutics Advanced Endovascular and Coronary Intervention Global Summit (C3), Orlando, FL, USA, share their impressions, thoughts and experiences with us at the 15th congress.
Featuring Dr Tim Fischell, Dr George Vetrovec, Dr Prakash Deedwania, Dr Saurabh Sanon, Dr Samir Pancholy, Dr Michael Lichtenberg, Dr C Michael Gibson, Dr Gianluca Rigatelli, Dr Sheldon Goldberg, Dr Dinesh Kalra, Professor Imad Sheiban, Dr Tudor Vagaonescu and Dr Lawrence Garcia.
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed in partnership with C3 at the 2019 annual meeting in Orlando, Florida, June 2019.
Share this Video
Related Videos In Interventional Cardiology
Peter Smits, ESC 2021 – High Bleeding Risk After Coronary Stenting
Dr Peter Smits (Interventional Cardiologist, Maasstad Hospital, Rotterdam, The Netherlands) kindly shared his thoughts on the major challenges in the treatment of patients at high bleeding risk after coronary stenting, with an overview of the recent key clinical trials involving percutaneous coronary intervention with stent deployment in patients at high bleeding risk, from the virtual ESC […]
David Keane, AF Symposium 2021: Challenges in Catheter Ablation
We spoke to Professor David Keane (St Vincent’s University Hospital, Dublin, Ireland) about the current challenges procedural duration and overall success in catheter ablation, and the most exciting innovations to aim to overcome these. Questions: What are the current challenges in catheter ablation in terms of procedural duration and overall success? (0.13) What are the […]
David Keane, AF Symposium 2021: Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy
We spoke to Professor David Keane (St Vincent’s University Hospital, Dublin, Ireland) about atrial fibrillation in patients with hypertrophic cardiomyopathy. Questions: What is the incidence of atrial fibrillation (AF) in people with hypertrophic cardiomyopathy (HCM)? (0.13) What is known about the efficacy and safety of catheter ablation of AF in patients with HCM compared to […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!